RxDoctor Payments Data

Heather Marks

Family · Meyersdale, PANPI 1366896342

Payments from drug & device makers

$2,998in general payments, 2019–2025

Across 174 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$446
  • Novo Nordisk$385
  • Lilly USA, LLC$256
  • Abbott$248
  • AstraZeneca$202
  • E.r. Squibb & Sons, L.L.C.$192
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$2,998100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,998 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban159$110,545
JardianceEmpagliflozin150$104,341
TrulicityDulaglutide94$98,493
OzempicSemaglutide81$84,893
MounjaroTirzepatide67$69,361
XareltoRivaroxaban62$44,899
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$31,995
Wellbutrin XlBupropion Hcl12$22,431
TradjentaLinagliptin35$20,181
Breo ElliptaFluticasone/Vilanterol39$19,158
JanuviaSitagliptin Phosphate17$17,553
Repatha SureclickEvolocumab16$14,092
RybelsusSemaglutide13$13,778
LinzessLinaclotide23$11,551
Praluent PenAlirocumab16$7,528

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$256$167,854161 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$48$130,223197 claims
PfizerEliquis$86$110,545159 claims
Novo NordiskOzempic, Rybelsus, Novolog$385$104,930112 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$110$56,789115 claims
MerckJanuvia$17$17,55317 claims
AbbVieLinzess, Synthroid$446$15,019107 claims
AstraZenecaBrilinta$202$6,92613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.

Other family in Meyersdale

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →